"Graves' Disease (Overactive Thyroid) Market – Industry Trends and Forecast to 2029
Global Graves' Disease (Overactive Thyroid) Market, By Diagnosis (Radioactive Iodine Uptake, Imaging Tests, Blood Tests, Others), Treatment (Radioactive iodine therapy, Medication, Others), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Specialty Clinics, Homecare, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others) – Industry Trends and Forecast to 2029
Data Bridge Market Research analyses that the Graves' disease (overactive thyroid) market was valued at USD 351.55 million in 2021 and is expected to reach USD 507.65 million by 2029, registering a CAGR of 4.70% during the forecast period of 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Access Full 350 Pages PDF Report @
https://www.databridgemarketresearch.com/reports/global-graves-disease-overactive-thyroid-market
Graves' disease (overactive thyroid), sometimes known as Basedow's disease, is an autoimmune condition that leads to hyperthyroidism. It occurs when the body's immune cells attack the thyroid, causing excessive thyroid hormone production. Graves' disease treatment aims to inhibit thyroid hormone production and block the hormones' effects on the body. Beta-blockers including propranolol and metoprolol are frequently used as first-line treatments. These medications help to keep your heart rate in check and safeguard it until other hyperthyroidism treatments take effect. Antithyroid drugs like methimazole (Tapazole) and propylthiouracil stop the thyroid gland from producing thyroid hormone. Radioiodine therapy entails taking a single dose of radioactive iodine in the form of a pill or a liquid. Radiation kills thyroid gland cells over a period of two to three months.
**Segments**
- Based on type, the Graves' Disease market can be segmented into primary hyperthyroidism, secondary hyperthyroidism, and tertiary hyperthyroidism. Each type of hyperthyroidism presents different challenges and treatment options, impacting the overall market dynamics.
- On the basis of treatment, the market can be segmented into medication, radioactive iodine therapy, and surgery. Each treatment option has its own set of benefits and risks, influencing patient choices and healthcare provider recommendations.
- Geographically, the market can be segmented into North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. The prevalence of Graves' Disease, treatment practices, and healthcare infrastructure vary across these regions, leading to diverse market opportunities and challenges.
**Market Players**
- Pfizer Inc.
- Sanofi
- Pfizer Inc.
- Mylan N.V.
- iX Biopharma Ltd.
- Merck & Co., Inc.
- Novartis AG
- Teva Pharmaceutical Industries Ltd.
- Lannett
- GlaxoSmithKline plc
https://www.databridgemarketresearch.com/reports/global-graves-disease-overactive-thyroid-marketThe Graves' Disease market is witnessing significant growth globally due to the increasing prevalence of hyperthyroidism and the rising awareness about the disorder. The market segmentation based on different types of hyperthyroidism, such as primary, secondary, and tertiary, allows for a targeted approach towards treatment and management strategies for healthcare providers. Primary hyperthyroidism is the most common form of hyperthyroidism in Graves' disease and is characterized by the overproduction of thyroid hormones by the thyroid gland. Secondary hyperthyroidism occurs due to abnormalities in the pituitary gland or hypothalamus, leading to excess thyroid hormone production. Tertiary hyperthyroidism is the rarest form and results from abnormalities in the hypothalamus.
In terms of treatment segmentation, medication remains the first-line approach for managing Graves' Disease by controlling the overproduction of thyroid hormones. Antithyroid medications such as methimazole and propylthiouracil are commonly used to reduce hormone levels. Radioactive iodine therapy is another treatment option that aims to destroy the thyroid gland's ability to produce hormones, often used when medications are not effective or relapse occurs. Surgery is usually reserved for cases where other treatment options have failed or are not suitable. These various treatment options provide patients and healthcare providers with choices based on individual needs and preferences.
Geographically, the Graves' Disease market shows variations in prevalence, treatment practices, and healthcare infrastructure across regions. North America and Europe hold a significant share of the market due to the high prevalence of hyperthyroidism in these regions and well-established healthcare systems. Asia-Pacific is expected to witness rapid growth in the market due to increasing awareness, improving healthcare infrastructure, and the rising prevalence of Graves' Disease. Latin America and the Middle East & Africa regions offer untapped market potential with growing healthcare expenditure and increasing focus on improving healthcare outcomes.
Market players in the Graves' Disease market play a vital role in driving innovation, research, and development of new treatment options. Companies**Global Graves' Disease (Overactive Thyroid) Market Analysis**
The global Graves' Disease market is experiencing substantial growth, driven by factors such as the increasing prevalence of hyperthyroidism and growing awareness about the disorder. The market segmentation based on different types of hyperthyroidism allows for a targeted treatment approach, enhancing healthcare providers' ability to implement effective management strategies. The primary type, characterized by thyroid hormone overproduction, is the most common form of hyperthyroidism in Graves' Disease. Secondary hyperthyroidism, resulting from abnormalities in the pituitary gland or hypothalamus, and tertiary hyperthyroidism, arising from abnormalities in the hypothalamus, present unique challenges in diagnosis and treatment.
In terms of treatment segmentation, medication remains the primary choice for managing Graves' Disease by controlling thyroid hormone overproduction. Antithyroid drugs like methimazole and propylthiouracil are commonly prescribed to reduce hormone levels. Radioactive iodine therapy, aiming to disable the thyroid gland's hormone production capability, is used when medications are ineffective or relapse occurs. Surgery is typically considered in cases where other treatment options fail. This diverse range of treatment options empowers patients and healthcare providers to make informed decisions based on individual requirements and preferences.
Geographically, the market dynamics vary across regions due to differences in the prevalence of Graves' Disease, treatment approaches, and healthcare infrastructure. North America and Europe dominate the market share due to the high incidence of hyperthyroid
Graves' Disease (Overactive Thyroid) Key Benefits over Global Competitors:
- The report provides a qualitative and quantitative analysis of the Graves' Disease (Overactive Thyroid) Market trends, forecasts, and market size to determine new opportunities.
- Porter’s Five Forces analysis highlights the potency of buyers and suppliers to enable stakeholders to make strategic business decisions and determine the level of competition in the industry.
- Top impacting factors & major investment pockets are highlighted in the research.
- The major countries in each region are analyzed and their revenue contribution is mentioned.
- The market player positioning segment provides an understanding of the current position of the market players active in the Personal Care Ingredients
Table of Contents: Graves' Disease (Overactive Thyroid) Market
1 Introduction
2 Global Graves' Disease (Overactive Thyroid) Market Segmentation
3 Executive Summary
4 Premium Insight
5 Market Overview
6 Graves' Disease (Overactive Thyroid) Market, by Product Type
7 Graves' Disease (Overactive Thyroid) Market, by Modality
8 Graves' Disease (Overactive Thyroid) Market, by Type
9 Graves' Disease (Overactive Thyroid) Market, by Mode
10 Graves' Disease (Overactive Thyroid) Market, by End User
12 Graves' Disease (Overactive Thyroid) Market, by Geography
12 Graves' Disease (Overactive Thyroid) Market, Company Landscape
13 Swot Analysis
14 Company Profiles
Critical Insights Related to the Graves' Disease (Overactive Thyroid) Included in the Report:
- Exclusive graphics and Illustrative Porter’s Five Forces analysis of some of the leading companies in this market
- Value chain analysis of prominent players in the market
- Current trends influencing the dynamics of this market across various geographies
- Recent mergers, acquisitions, collaborations, and partnerships
- Revenue growth of this industry over the forecast period
- Marketing strategy study and growth trends
- Growth-driven factor analysis
- Emerging recess segments and region-wise market
- An empirical evaluation of the curve of this market
- Ancient, Present, and Probable scope of the market from both prospect value and volume
Browse Trending Reports:
Mouth Freshener Market
Biological Molluscicides Market
Traffic Management Market
Sexual Wellness Market
Organic Poultry Feed Market
Gammaretroviral Vector Market
Infrastructure Inspection Market
Scented Candle Market
Cloud Backup Market
Online Testing Software Market
Real Time Parking System Market
Mobile Cases And Covers Market
Toxic Epidermal Necrolysis Market
Weather Monitoring Solutions And Services Market
Electronic Records Management Solutions Market
Seed Coating Colorants Market
Huntingtons Disease Treatment Market
Specimen Collection Kit Market
Finished Lubricant Market
Specimen Validity Testing Market
Immunoprotein Diagnostic Testing Market
Satellite Transponder Market
Building Thermal Insulation Market
Broadband Internet Access Services Market
Microalgae In Feed Market
About Data Bridge Market Research:
Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Contact Us:
Data Bridge Market Research
US: +1 614 591 3140
UK: +44 845 154 9652
APAC : +653 1251 975
